Last Close
15.61 $
Jul 2, 26
Market Cap
2.1 B $
Q1 2026 (TTM)
52-Week Range
%+108.4
%44.8
0.98
1.09
%-16.2
-%16.2
1M
+1.4%
3M
+0.0%
6M
-2.1%
YTD
-2.1%
1Y
+108.4%
3Y
+56.3%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
AUPH last closed at 15.61 $ (Jul 2, 26). Price data is refreshed after every trading day.
Aurinia Pharmaceuticals Inc trades at a trailing-twelve-month P/E of 7.20. See the comparison tables on the Peers tab for the industry context.
Aurinia Pharmaceuticals Inc (AUPH) has a market capitalization of approximately 2.1 B $ as of the latest reported period.
Key peers of Aurinia Pharmaceuticals Inc include TELIX Pharmaceuticals Ltd, Mesoblast Ltd, CSL Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.